Skip to main content
Premium Trial:

Request an Annual Quote

J&Jer Moves to Caliper as Diagnostic Diva


The new vice president at Caliper Technologies is having her cake and eating it too.

Susan Evans, who took up the reins of VP of product development, wears two hats: one of manager, and the other, scientist.

“One of the nice things about being at Caliper is that I get to do both,” Evans says. “That’s one of the advantages about being in a smaller company that has such a strong science and technology foundation. In the end you’re not only managing the business aspects but the technical side too.”

Evans brings to the seven-year-old, Mountain View, Calif.-based company experience from LifeScan, a Johnson & Johnson company, where she was vice president of R&D; she also worked at clinical diagnostic firm Dade Behring as a senior veep.

Despite 20 years of research and product development in the medical diagnostic industry, Evans was lured to Caliper by its palm-sized chips. “It’s an exciting new technology,” she says. “It’s a technology that not only has the potential of applications in the research market and high-throughput screening market, but also in clinical diagnostics.”

She believes her in-depth understanding of the diagnostics market could usher Caliper’s technology into that field, where higher throughput, miniaturization, efficiency, accuracy, and quality are vital.

— Jasmin Chua

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.